Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
14 Sept 2024, 6:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tab Oxcarbazepine 300mg
Escitalopran 10mg Tab
Inj Triamcinolone Acetate 10 mg per ml
Vit B1 50 mg Inj
Tab Sertaline 50mg
6822568
GEM/2024/B/5325825
Two Packet Bid
Tab Oxcarbazepine 300mg,Escitalopran 10mg Tab,Inj Triamcinolone Acetate 10 mg per ml,Vit B1 50 mg I
15 days
Bihar; Gaya
Total value wise evaluation
BOQ
4 documents required · 4 mandatory
Exempted
15 Sept 2024
24 Aug 2024
14 Sept 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 010537 | Tab Oxcarbazepine 300mg | 6,000 | No | GAYA | 15 | |
| 012318 | Escitalopran 10mg Tab | 3,600 | No | GAYA | 15 | - |
| 011374 | Inj Triamcinolone Acetate 10 mg per ml | 30 | Vial | GAYA | 15 | |
| 012706 | Vit B1 50 mg Inj | 60 | Vial | GAYA | 15 | |
| 012368 | Tab Sertaline 50mg | 3,000 | No | GAYA | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6822568.pdf
GEM_BID
item_specification_bid-_12_2024-08-24-17-50-51_c9cb2efceab61809a4a7abfe9f241ed3.pdf
BOQ
boq_item_sample_file_2024-08-24-17-50-51_c19d31d5dcd5b97157fe23d506d268c4.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .